Medicine and Dentistry
Neoplasm
100%
Positron Emission Tomography-Computed Tomography
99%
Positron Emission Tomography
96%
Polyethylene Terephthalate
65%
Fluorodeoxyglucose F 18
61%
Fluorine-18
39%
Iodine 131
33%
Fluorodeoxyglucose
30%
Radioactive Tracer
30%
Breast Cancer
28%
Computer Assisted Tomography
25%
Single-Photon Emission Computed Tomography
25%
Non-Hodgkin Lymphoma
24%
Dosimetry
23%
Standardized Uptake Value
22%
Radioimmunotherapy
21%
Nuclear Medicine
20%
Malignant Neoplasm
20%
Diseases
16%
Tositumomab
15%
Cancer
15%
Monoclonal Antibody
14%
Metastatic Carcinoma
14%
Glucose Uptake
14%
Melanoma
14%
Radiopharmaceutical
14%
Magnetic Resonance Imaging
12%
In Vitro
12%
Lymph Node
12%
Scintigraphy
12%
Lung
12%
Molecular Imaging
11%
Oncology
11%
Technetium-99
10%
Brown Adipose Tissue
10%
Radioisotope
10%
Quantitative Imaging
10%
Absorbed Dose
10%
Cancer Cell
9%
Clinical Trial
9%
Neck
9%
Lung Cancer
9%
Single Photon Emission Computed Tomography-Computed Tomography
9%
Breast Carcinoma
8%
Radiation Therapy
8%
Thyroid Cancer
8%
Treatment Response
8%
Radioactive Iodine
8%
Recurrent Disease
8%
Diagnosis
8%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
84%
Tumor
77%
Positron Emission Tomography
73%
Fluorodeoxyglucose
60%
18F-FDG PET-CT
32%
Single-photon Emission Computed Tomography (SPECT)
31%
Radioimmunotherapy
30%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
26%
Standardized Uptake Value
26%
Monoclonal Antibody
24%
Computed Tomography
24%
Non-Hodgkin Lymphoma
23%
Iodine-131 (131I)
22%
Brown Adipose Tissue
21%
Lymphoma
20%
FDG Uptake
20%
Tositumomab
20%
Breast Cancer
19%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
18%
Fluorine-18
18%
Whole-body
17%
Liver
17%
Dosimetry
16%
Attenuation Correction
15%
18F-fluorodeoxyglucose (18F-FDG)
14%
Radiolabeled Antibody
13%
Nuclear Medicine
13%
Quantitative Imaging
13%
Glucose Uptake
13%
Lung
13%
Radiation Dose
12%
125I
12%
Repeatability
11%
Three-dimensional (3D)
10%
Absorbed Dose
10%
Melanoma
10%
PET Imaging
10%
Biodistribution
9%
F-18
9%
Tracer Uptake
9%
Tumor Uptake
9%
Radionuclides
9%
PET Image
9%
Nuclear Imaging
9%
Technetium-99m
9%
Magnetic Resonance Imaging
9%
Treatment Planning
9%
Clinical Trials
9%
I-131
8%
Radioactivity
8%